Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Rachel K Wee, Hiroyuki Takamatsu, MD PhD, Ryoichi Murata, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Naoki Takezako, MD PhD, Shigeki Ito, MD PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, MD PhD, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, MD PhD, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2015) 126 (23): 1782.

https://doi.org/10.1182/blood.V126.23.1782.1782

Published: 2015

Journal Articles

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma

Hiroyuki Takamatsu, MD PhD, Ryoichi Murata, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Naoki Takezako, MD PhD, Shigeki Ito, MD, PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, MD PhD, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, MD PhD, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2014) 124 (21): 2003.

https://doi.org/10.1182/blood.V124.21.2003.2003

Published: 2014

Journal Articles

Next-Generation IgVH Sequencing of Monoclonal B-Cell Lymphocytosis Reveals Clonal Heterogeneity, Ongoing Mutation, and Repertoire Differences Relative to Chronic Lymphocytic Leukemia

Mark Klinger, Malek Faham, Jianbiao Zheng, PhD, Kojo S.J. Elenitoba-Johnson, MD, Sherrie L. Perkins, MD PhD, David W Bahler, MD PhD

Blood (2014) 124 (21): 1960.

https://doi.org/10.1182/blood.V124.21.1960.1960

Published: 2014

Journal Articles

Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma

Mark Roschewski, MD, Kieron Dunleavy, MD, Stefania Pittaluga, Katie Kong, Margaret Shovlin, RN, Elaine S. Jaffe, Louis M. Staudt, MD PhD, Catherine Lai, MD MPH, Clara C. Chen, MD, Jianbiao Zheng, PhD, Thomas D. Willis, PhD, Malek Faham, Wyndham H Wilson, MD PhD

Blood (2014) 124 (21): 139.

https://doi.org/10.1182/blood.V124.21.139.139

Published: 2014

Journal Articles

A Comparison Between Next-Generation Sequencing and ASO-qPCR For Minimal Residual Disease Detection In Multiple Myeloma: The Clinical Value In ASCT Setting

Hiroyuki Takamatsu, MD, PhD, Ryoichi Mura, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Terasaki Yasushi, MD, PhD, Yoshida Takashi, MD, PhD, Malek Faham, MD, PhD, Shinji Nakao, MD, PhD

Blood (2013) 122 (21): 1843.

https://doi.org/10.1182/blood.V122.21.1843.1843

Published: 2013

Journal Articles

DNA Sequencing-Based Monitoring Of Serum Predicts Clinical Relapse Before CT Imaging in Diffuse Large B-Cell Lymphoma

Mark Roschewski, MD, Stefania Pittaluga, MD, Kieron Dunleavy, MD, Katherine Kong, MS, Margaret Shovlin, RN, Elaine S. Jaffe, MD, Louis M. Staudt, MD, PhD, Jianbiao Zheng, PhD, Tom Willis, PhD, Malek Faham, MD, PhD, Wyndham H Wilson, MD, PhD

Blood (2013) 122 (21): 1767.

https://doi.org/10.1182/blood.V122.21.1767.1767

Published: 2013

Journal Articles

Alloreactive T Cell Clonotypes Identified By In Vitro Mixed Lymphoid Reaction and High-Throughput Sequencing Exhibit Increased Frequency In Peripheral Blood Samples From Patients Following Allogeneic Hematopoietic Cell Transplantation For Chronic Lymphocytic Leukemia

Aaron C. Logan, MD, PhD, Mark R. Krampf, MS, Mark Klinger, PhD, Martin Moorhead, PhD, Jianbiao Zheng, PhD, Randall Armstrong, Malek Faham, MD, PhD, Kenneth I Weinberg, MD, David B. Miklos, MD, PhD

Blood (2013) 122 (21): 149.

https://doi.org/10.1182/blood.V122.21.149.149

Published: 2013

Journal Articles

Comparison of Minimal Residual Disease Detection Using High-Throughput Sequencing and Allele-Specific Oligonucleotide PCR Methods in Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Marian Harris, MD, Malek Faham, MD, PhD, Lei Fang, PhD, Martin Moorhead, PhD, Jianbiao Zheng, PhD, Donna S. Neuberg, ScD, Stephen E. Sallan, MD, Lewis B. Silverman, MD, Kristen E. Stevenson, MS

Blood (2012) 120 (21): 2532.

https://doi.org/10.1182/blood.V120.21.2532.2532

Published: 2012

Journal Articles

Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia Using High-Throughput Sequencing of Multiple Immunoreceptor Genes Predicts Relapse and Survival After Allogeneic Hematopoietic Cell Transplantation.

Aaron C. Logan, MD, PhD, Nikita Vashi, BS, Malek Faham, MD, PhD, Victoria Carlton, PhD, Ismael Buno, PhD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Mark Klinger, PhD, Tom Willis, PhD, Bing Zhang, MD, Amna Waqar, BS, James L. Zehnder, David B Miklos, MD, PhD

Blood (2012) 120 (21): 2512.

https://doi.org/10.1182/blood.V120.21.2512.2512

Published: 2012

Journal Articles

Clonosight: A Standardized Clinical Assay for Measurement of Minimal Residual Disease in Leukemias and Lymphomas

Thomas D. Willis, PhD, Tom Asbury, PhD, Victoria Carlton, PhD, Lei Fang, PhD, Mark Klinger, PhD, Martin Moorhead, PhD, Kaliprasad Pothuraju, MS, Li Weng, PhD, Jianbiao Zheng, PhD, Malek Faham, MD, PhD

Blood (2012) 120 (21): 1434.

https://doi.org/10.1182/blood.V120.21.1434.1434

Published: 2012

Journal Articles

Comparison of High-Throughput Sequencing and Flow Cytometry for Measuring Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Children's Oncology Group Cohort

Charles Gawad, MD, Michael J. Borowitz, MD, PhD, Gary V. Dahl, MD, Meenakshi Devidas, PhD, Malek Faham, MD, PhD, Martin Moorhead, PhD, Brent L. Wood, MD, PhD, Jianbiao Zheng, PhD, Mignon L. Loh, MD, Norman J. Lacayo, MD

Blood (2012) 120 (21): 1440.

https://doi.org/10.1182/blood.V120.21.1440.1440

Published: 2012

Journal Articles

Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Malek Faham, MD, PhD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Victoria Carlton, Patricia Lee Stow, BA, MS, Elaine Coustan-Smith, MS, Ching-Hon Pui, MD, Dario Campana, MD, PhD

Blood (2012) 120 (21): 1388.

https://doi.org/10.1182/blood.V120.21.1388.1388

Published: 2012

Journal Articles

Highly Sensitive Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia Using Next-Generation Sequencing of Immunoglobulin Heavy Chain Variable Region

Malek Faham, MD, PhD, Tom Willis, PhD, Martin Moorhead, PhD, Victoria Carlton, PhD, Jianbiao Zheng, PhD, Dario Campana, MD, PhD

Blood (2011) 118 (21): 2540.

https://doi.org/10.1182/blood.V118.21.2540.2540

Published: 2011

Journal Articles

High-Throughput Immunoglobulin Gene Sequencing Quantifies Minimal Residual Disease in CLL with 10e-6 Sensitivity and Strongly Predicts Relapse After Allogeneic Hematopoietic Cell Transplantation

Aaron C. Logan, MD, PhD, Malek Faham, MD, PhD, Victoria Carlton, PhD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Tom Willis, PhD, Carol D. Jones, Melody B. Zhang, PhD, Amna N. Waqar, James L. Zehnder, MD, David B. Miklos, MD, PhD

Blood (2011) 118 (21): 2542.

https://doi.org/10.1182/blood.V118.21.2542.2542

Published: 2011

Journal Articles

Next-Generation Sequencing of Immunoglobulin Heavy Chain Variable Region in Diagnostic Samples of Pediatric Acute Lymphoblastic Leukemia Identifies Hundreds of Clonal Subpopulations with Multiple Immunophenotypes

Charles Gawad, MD, Malek Faham, MD, PhD, Tom Willis, PhD, Martin Moorhead, PhD, Victoria Carlton, PhD, Jianbiao Zheng, PhD, Mark Klinger, Gary V Dahl, MD, Norman J. Lacayo, MD

Blood (2011) 118 (21): 1436.

https://doi.org/10.1182/blood.V118.21.1436.1436

Published: 2011

Journal Articles

Massively Parallel Immunoglobulin Gene Sequencing Provides Ultra-Sensitive Minimal Residual Disease Detection and Predicts Post-Transplant Relapse in Acute Lymphoblastic Leukemia by Three to Six Months,

Aaron C. Logan, MD, PhD, Nikita Vashi, BS, Malek Faham, MD, PhD, Victoria Carlton, PhD, Ismael Buno, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Mark Klinger, PhD, Tom Willis, PhD, Melody B. Zhang, PhD, Amna Waqar, James L. Zehnder, MD, David B. Miklos, MD, PhD

Blood (2011) 118 (21): 4104.

https://doi.org/10.1182/blood.V118.21.4104.4104

Published: 2011

Journal Articles

Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results

Joshua D Brody, MD, Debra Katherine Czerwinski, Victoria Carlton, Martin Moorhead, PhD, Jianbiao Zheng, PhD, Mark Klinger, PhD, Malek Faham, MD, PhD, Ranjana Advani, MD, Holbrook E Kohrt, MD, Arash Ash Alizadeh, MD, PhD, Robert S Negrin, MD, Wen-Kai Weng, MD, PhD, Kevin Sheehan, PhD, Ronald Levy, MD

Blood (2011) 118 (21): 3068.

https://doi.org/10.1182/blood.V118.21.3068.3068

Published: 2011

NARROW

A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma

Next-Generation IgVH Sequencing of Monoclonal B-Cell Lymphocytosis Reveals Clonal Heterogeneity, Ongoing Mutation, and Repertoire Differences Relative to Chronic Lymphocytic Leukemia

Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma

A Comparison Between Next-Generation Sequencing and ASO-qPCR For Minimal Residual Disease Detection In Multiple Myeloma: The Clinical Value In ASCT Setting

DNA Sequencing-Based Monitoring Of Serum Predicts Clinical Relapse Before CT Imaging in Diffuse Large B-Cell Lymphoma

Alloreactive T Cell Clonotypes Identified By In Vitro Mixed Lymphoid Reaction and High-Throughput Sequencing Exhibit Increased Frequency In Peripheral Blood Samples From Patients Following Allogeneic Hematopoietic Cell Transplantation For Chronic Lymphocytic Leukemia

Comparison of Minimal Residual Disease Detection Using High-Throughput Sequencing and Allele-Specific Oligonucleotide PCR Methods in Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia Using High-Throughput Sequencing of Multiple Immunoreceptor Genes Predicts Relapse and Survival After Allogeneic Hematopoietic Cell Transplantation.

Clonosight: A Standardized Clinical Assay for Measurement of Minimal Residual Disease in Leukemias and Lymphomas

Comparison of High-Throughput Sequencing and Flow Cytometry for Measuring Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Children's Oncology Group Cohort

Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Highly Sensitive Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia Using Next-Generation Sequencing of Immunoglobulin Heavy Chain Variable Region

High-Throughput Immunoglobulin Gene Sequencing Quantifies Minimal Residual Disease in CLL with 10e-6 Sensitivity and Strongly Predicts Relapse After Allogeneic Hematopoietic Cell Transplantation

Next-Generation Sequencing of Immunoglobulin Heavy Chain Variable Region in Diagnostic Samples of Pediatric Acute Lymphoblastic Leukemia Identifies Hundreds of Clonal Subpopulations with Multiple Immunophenotypes

Massively Parallel Immunoglobulin Gene Sequencing Provides Ultra-Sensitive Minimal Residual Disease Detection and Predicts Post-Transplant Relapse in Acute Lymphoblastic Leukemia by Three to Six Months,

Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only